Senator to Investigate FDA Rejections of Rare Disease Drugs

(MedPage Today) — Sen. Ron Johnson (R-Wisc.) said Tuesday he will open an investigation into the FDA’s handling of applications for approval of biological therapies to treat Duchenne muscular dystrophy (DMD) and other rare, life-threatening disorders…